NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-127-2017-0-CA-04 Combination PDL1 And TGF Beta Blockade In Patients With HPV+ Malignancies CA National Stage 3063087 Abandoned
NIDCR E-485-2013-2-US-01 COMPOSITIONS AND METHODS FOR THE INHIBITION OF PRURITUS US 62/667,843 Abandoned
NIAID E-067-2016-3-US-03 METHOD OF VACCINATION WITH AN ATTENUATED RSV VACCINE FORMULATION US National Stage 15/773,653 12102671 Abandoned PDF
NCI E-291-2012-0-RU-13 M971 Chimeric Antigen Receptors RU DIV 2018116582 Issued
NICHD E-210-2021-0-US-03 Kits And Methods For Predictions And Treatment Of Preeclampsia US National Stage 15/773,978 11243213 Issued PDF
NICHD E-209-2021-0-US-02 Kits And Methods To Distinguish False Labor And True Labor US National Stage 15/773,980 11204354 Issued PDF
NCI E-069-2017-0-EP-04 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL EP National Stage 18727506.0 Issued
NCI E-069-2017-0-GB-08 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL GB EP 18727506.0 Issued
NCI E-069-2017-0-FR-07 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL FR EP 18727506.0 Issued
NCI E-069-2017-0-CH-05 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL CH EP 18727506.0 Issued
NCI E-069-2017-0-DE-06 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL DE EP 18727506.0 Issued
NCI E-010-2016-2-US-09 ANTI-BCMA POLYPEPTIDES AND PROTEINS US National Stage 15/773,687 10925969 Issued PDF
NIDCR E-485-2013-0-US-04 METHODS OF TREATING OR PREVENTING PRURITIS BY BLOCKING NATRIURETIC POLYPEPTIDE
B 		US DIV 15/971,671 10583173 Issued PDF
NCI E-069-2017-0-PCT-02 METHODS OF PREPARING A RE-USABLE SINGLE CELL AND METHODS FOR ANALYZING THE EPIGENOME, TRANSCRIPTOME, AND GENOME OF A SINGLE CELL PCT PCT PCT/US2018/031201 Expired
NCI E-285-2016-2-US-06 Glypican 2 As A Cancer Marker And Therapeutic Target US National Stage 15/773,256 11814440 Issued PDF
NCI E-055-2017-0-US-05 Combing D2C7 Immunotoxin With Check Points Inhibitors US National Stage 15/773,418 11065332 Issued PDF
NCI E-188-2010-1-US-04 Human Monoclonal Antibody Against Human Folate Receptor Beta US CON 15/970,352 Abandoned
NCI E-123-2018-0-US-01 PEPTIDE HYDROGELS FOR DELIVERY OF IMMUNOSUPPRESSIVE DRUGS AND USES THEREOF US 62/666,471 Abandoned
NCI E-010-2016-2-AU-02 Anti-BCMA Polypeptides and Proteins AU National Stage 2016353067 Issued
NCI E-257-2009-1-US-23 USE OF IL-15 TO INCREASE THYMIC OUTPUT AND TO TREAT LYMPHOPENIA US DIV 15/969,647 10894816 Issued PDF
NCI E-291-2012-0-JP-14 M971 Chimeric Antigen Receptors JP DIV 2018-088908 Issued
NEI E-251-2012-3-US-16 METHOD FOR GENERATING RETINAL PIGMENT EPITHELIUM (RPE) CELLS FROM INDUCED PLURIPOTENT STEM CELLS (IPSCs) US CON 15/969,686 10480031 Issued PDF
NIAID E-079-2018-0-US-01 Antibodies and Methods for the Diagnosis, Prevention, and Treatment of Epstein Barr Virus Infection US 62/665,977 Abandoned
NCI E-109-2016-0-JP-10 TARGETED CANCER THERAPY JP National Stage 2018-542994 Abandoned
NCI E-098-2018-0-US-01 T CELL RECEPTORS WHICH RECOGNIZE MUTATED EGFR US 62/665,234 Abandoned
NCI E-208-2015-0-KR-06 Thalidomide Analogs and Methods of Use KR National Stage 10-2018-7012347 Issued
NIAID E-133-2015-0-IN-06 NEUTRALIZING ANTIBODIES TO HIV 1 GP41 AND THEIR USE IN National Stage 201837016184 Issued
NIAID E-133-2015-0-US-07 NEUTRALIZING ANTIBODIES TO HIV-1 GP41 AND THEIR USE US National Stage 15/772,443 11236152 Issued PDF
NCI E-109-2016-0-US-03 TARGETED CANCER THERAPY US National Stage 15/772,134 11207339 Issued PDF
NCATS E-050-2012-0-AU-12 Cyclodextrin For The Treatment Of Lysosomal Storage Diseases AU DIV 2018202964 Issued
NCI E-108-2016-0-US-03 Papillomavirus Virus-like Particles For Increasing The Effectiveness And Safety Of CAR-based Adoptive Cell Therapy Of Cancer US National Stage 15/772,152 Abandoned
NIEHS E-125-2018-0-US-01 Targeting Epithelial Membrane Protein 2 To Protect Respiratory Epithelial Barrier Integrity During Lung Infection And Inflammation US 62/664,805 Abandoned
NCI E-187-2015-0-US-07 COMPOSITIONS AND METHODS FOR THE TREATMENT OF HER2-EXPRESSING SOLID TUMORS US National Stage 15/771,932 11266726 Issued PDF
NCI E-256-2008-0-US-13 SURVIVAL PREDICTOR FOR DIFFUSE LARGE B CELL LYMPHOMA US CON 15/965,510 11028444 Issued PDF
NCI E-103-2021-0-US-01 Use Of Lentivector - Transduced T-RAPA Cells For Amelioration Of Lysosomal Storage Disorders US 62/663,786 Abandoned
NHLBI E-222-2022-2-US-01 Catheters and Manipulators with Deflectable Ends US 62/663,518 Expired
NCATS E-198-2016-0-EP-05 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling EP National Stage 18790880.1 Issued
NCATS E-198-2016-0-GB-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling GB EP 18790880.1 Issued
NCATS E-198-2016-0-DE-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling DE EP 18790880.1 Issued
NCATS E-198-2016-0-FR-01 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling FR EP 18790880.1 Issued
NCATS E-198-2016-0-CN-06 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling CN National Stage 201880042610.4 Issued
NCATS E-198-2016-0-JP-07 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling JP National Stage 2019-558704 Issued
NCI E-059-2013-0-JP-10 Methods of Producing Enriched Populations of Tumor-Reactive T Cells From Tumor JP DIV 2018-085761 Issued
NCATS E-198-2016-0-PCT-02 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling PCT PCT PCT/US2018/029626 Expired
NCI E-128-2017-0-PCT-02 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS PCT PCT PCT/US2018/029623 Expired
NCI E-128-2017-0-EP-03 DEVICE FOR STORING AND TRANSPORTING TISSUE SPECIMENS EP National Stage 18724092.4 Pending
NIMH E-126-2018-0-US-01 NR2B LIGANDS; METHOD OF MAKING; AND USE THEREOF US 62/663,085 Abandoned
NCATS E-198-2016-0-CA-03 Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling CA National Stage 3059232 Pending
NIAID E-001-2017-1-PCT-01 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION PCT PCT COMB PCT/US2018/029463 Expired
NIAID E-001-2017-1-EP-02 ANTIBODIES AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF EPSTEIN BARR VIRUS INFECTION EP National Stage 18724410.8 Pending